136 related articles for article (PubMed ID: 32727785)
1. Exploring Flavonoids for Potential Inhibitors of a Cancer Signaling Protein PI3Kγ Kinase Using Computational Methods.
Rehan M; Mahmoud MM; Tabrez S; Hassan HMA; Ashraf GM
Anticancer Res; 2020 Aug; 40(8):4547-4556. PubMed ID: 32727785
[TBL] [Abstract][Full Text] [Related]
2. Anticancer compound XL765 as PI3K/mTOR dual inhibitor: A structural insight into the inhibitory mechanism using computational approaches.
Rehan M
PLoS One; 2019; 14(6):e0219180. PubMed ID: 31247018
[TBL] [Abstract][Full Text] [Related]
3. Water Molecules Increases Binding Affinity of Natural PI3Kγ Inhibitors Against Cancer.
Sharma P; Shukla A; Kalani K; Dubey V; Srivastava SK; Luqman S; Khan F
Curr Comput Aided Drug Des; 2015; 11(4):304-20. PubMed ID: 26603929
[TBL] [Abstract][Full Text] [Related]
4. A multi-conformational virtual screening approach based on machine learning targeting PI3Kγ.
Zhu J; Jiang Y; Jia L; Xu L; Cai Y; Chen Y; Zhu N; Li H; Jin J
Mol Divers; 2021 Aug; 25(3):1271-1282. PubMed ID: 34160714
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells.
Zhang HW; Hu JJ; Fu RQ; Liu X; Zhang YH; Li J; Liu L; Li YN; Deng Q; Luo QS; Ouyang Q; Gao N
Sci Rep; 2018 Jul; 8(1):11255. PubMed ID: 30050147
[TBL] [Abstract][Full Text] [Related]
6. Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.
Zhu J; Li K; Xu L; Jin J
Chem Biol Drug Des; 2019 May; 93(5):818-831. PubMed ID: 30582283
[TBL] [Abstract][Full Text] [Related]
7. In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target.
Sharma P; Shukla A; Kalani K; Dubey V; Luqman S; Srivastava SK; Khan F
Curr Cancer Drug Targets; 2017; 17(8):722-734. PubMed ID: 28359246
[TBL] [Abstract][Full Text] [Related]
8. Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool.
Suhail M; AlZahrani WM; Shakil S; Tarique M; Tabrez S; Zughaibi TA; Rehan M
Front Pharmacol; 2023; 14():1236173. PubMed ID: 37900167
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
[TBL] [Abstract][Full Text] [Related]
10. Recent discovery of phosphoinositide 3-kinase γ inhibitors for the treatment of immune diseases and cancers.
Qiu X; Tian Y; Liang Z; Sun Y; Li Z; Bian J
Future Med Chem; 2019 Aug; 11(16):2151-2169. PubMed ID: 31538525
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
Collier PN; Martinez-Botella G; Cornebise M; Cottrell KM; Doran JD; Griffith JP; Mahajan S; Maltais F; Moody CS; Huck EP; Wang T; Aronov AM
J Med Chem; 2015 Jan; 58(1):517-21. PubMed ID: 24754609
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of Novel Phosphoinositide 3-Kinase Gamma (PI3Kγ) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Li K; Zhu J; Xu L; Jin J
Chem Biodivers; 2019 Jul; 16(7):e1900105. PubMed ID: 31111650
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
Raj U; Kumar H; Varadwaj PK
J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
[TBL] [Abstract][Full Text] [Related]
14. Study on Structure Activity Relationship of Natural Flavonoids against Thrombin by Molecular Docking Virtual Screening Combined with Activity Evaluation In Vitro.
Wang X; Yang Z; Su F; Li J; Boadi EO; Chang YX; Wang H
Molecules; 2020 Jan; 25(2):. PubMed ID: 31968628
[TBL] [Abstract][Full Text] [Related]
15. Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; in silico and in vitro.
Singh P; Bast F
Invest New Drugs; 2015 Jun; 33(3):575-93. PubMed ID: 25895100
[TBL] [Abstract][Full Text] [Related]
16. A class of highly selective inhibitors bind to an active state of PI3Kγ.
Gangadhara G; Dahl G; Bohnacker T; Rae R; Gunnarsson J; Blaho S; Öster L; Lindmark H; Karabelas K; Pemberton N; Tyrchan C; Mogemark M; Wymann MP; Williams RL; Perry MWD; Papavoine T; Petersen J
Nat Chem Biol; 2019 Apr; 15(4):348-357. PubMed ID: 30718815
[TBL] [Abstract][Full Text] [Related]
17. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.
Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV
Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424
[TBL] [Abstract][Full Text] [Related]
18. Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.
Zhu J; Li K; Yu L; Chen Y; Cai Y; Jin J; Hou T
Med Res Rev; 2021 May; 41(3):1599-1621. PubMed ID: 33300614
[TBL] [Abstract][Full Text] [Related]
19. SAR, QSAR and docking of anticancer flavonoids and variants: a review.
Scotti L; Bezerra Mendonça Junior FJ; Magalhaes Moreira DR; da Silva MS; Pitta IR; Scotti MT
Curr Top Med Chem; 2012; 12(24):2785-809. PubMed ID: 23368103
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential flavonoid inhibitors of glyoxalase-I based on virtual screening and in vitro studies.
Yadav A; Kumar R; Sunkaria A; Singhal N; Kumar M; Sandhir R
J Biomol Struct Dyn; 2016 May; 34(5):993-1007. PubMed ID: 26108947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]